Jump to content

Stem bromelain

From Wikipedia, the free encyclopedia
Stem bromelain
Identifiers
EC no.3.4.22.32
CAS no.37189-34-7
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Search
PMCarticles
PubMedarticles
NCBIproteins

Stem bromelain (SBM) (EC 3.4.22.32), a proteolytic enzyme, is a widely accepted phytotherapeutical drug member of the bromelain family of proteolytic enzymes obtained from Ananas comosus.[1] Some of the therapeutic uses of SBM are reversible inhibition of platelet aggregation, angina pectoris, bronchitis, sinusitis, surgical traumas, thrombophlebitis, pyelonephritis and enhanced absorption of drugs, particularly of antibiotics. Its anti-metastasis and anti-inflammatory activities are apparently independent of its proteolytic activity. Although poorly understood, the diverse pleiotrophic effects of SBM seem to depend on its ability to traverse the membrane barrier, a very unusual property of this protein.

References

[edit]
  1. ^ Schomburg D, Stephan D (1998). "Stem bromelain". Enzyme Handbook. Vol. 16. Heidelberg: Springer, Berlin. pp. 51–58. doi:10.1007/978-3-642-58903-4_9. ISBN 978-3-642-58903-4.
[edit]